Diazepam (DZP) antibody and antigen (hapten, BSA/OVA conjugated)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-SMT-203-Ag01	BSA-Diazepam (DZP)	756
GMP-SMT-203-Ag02	OVA-Diazepam (DZP)	756
GMP-SMT-203-Ab01	Anti-human Diazepam (DZP) mouse monoclonal antibody (mAb)	1953
GMP-SMT-203-Ab02	Anti-human Diazepam (DZP) human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-SMT-203-Ag01
Product Name	BSA-Diazepam (DZP)
Target/Biomarker	Diazepam (DZP)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Diazepam (DZP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in DZP level test of Inflammation/autoimmune/inflammatory disease (anxiety, seizures, muscle spasms) and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Diazepam (DZP) / OVA-Diazepam (DZP) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-203-Ag02
Product Name	OVA-Diazepam (DZP)
Target/Biomarker	Diazepam (DZP)
Expression platform	Synthetic
Isotypes	NA
Bioactivity validation	Diazepam (DZP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in DZP level test of Inflammation/autoimmune/inflammatory disease (anxiety, seizures, muscle spasms) and related syndrome evaluation.
Tag	NA
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Diazepam (DZP) / OVA-Diazepam (DZP) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-203-Ab01
Product Name	Anti-human Diazepam (DZP) mouse monoclonal antibody (mAb)
Target/Biomarker	Diazepam (DZP)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Diazepam (DZP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in DZP level test of Inflammation/autoimmune/inflammatory disease (anxiety, seizures, muscle spasms) and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Diazepam (DZP) / OVA-Diazepam (DZP) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-SMT-203-Ab02
Product Name	Anti-human Diazepam (DZP) human monoclonal antibody (mAb)
Target/Biomarker	Diazepam (DZP)
Expression platform	Hybridoma
Isotypes	Mouse IgG
Bioactivity validation	Diazepam (DZP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in DZP level test of Inflammation/autoimmune/inflammatory disease (anxiety, seizures, muscle spasms) and related syndrome evaluation.
Tag	mFc
Products description	Competitive immunoassay-validated hapten-carrier conjugates BSA-Diazepam (DZP) / OVA-Diazepam (DZP) is Synthetic.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Diazepam and its Significance in In Vitro Diagnosis (IVD): Diazepam, a prominent benzodiazepine medication, assumes a pivotal role in the sphere of in vitro diagnosis (IVD). It serves as a primary target molecule for diagnostic assays, and our company specializes in providing a comprehensive suite of resources, including anti-Diazepam antibodies and an extensive range of small molecule competitive antigens. These antigens are meticulously crafted in various forms, such as Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated variants. These meticulously engineered reagents are purposefully designed to facilitate the precise and sensitive detection of Diazepam within a diverse range of sample matrices. The Imperative of Diazepam Measurement: a. Therapeutic Drug Monitoring (TDM): Diazepam represents a frequently prescribed medication, aiding individuals in managing various conditions, including anxiety, muscle spasms, and seizures. In the realm of therapeutic drug monitoring (TDM), precise Diazepam measurement becomes imperative. It ensures that patients receive the optimal dosage necessary to maintain therapeutic levels, thereby enhancing treatment efficacy while minimizing the risk of adverse effects or suboptimal therapeutic outcomes. b. Clinical Toxicology: Due to its potential for misuse and abuse, Diazepam assumes a central role in the field of clinical toxicology. Diazepam testing is pivotal in monitoring patients undergoing addiction treatment programs, detecting potential overdose cases, and facilitating the comprehensive management of substance abuse disorders. Accurate quantification of Diazepam levels in biological specimens is instrumental in guiding treatment decisions and ensuring patient safety. c. Forensic Investigations: The role of Diazepam extends to forensic investigations, particularly in cases where drug-related incidents, accidents, or legal matters are involved. Diazepam analysis in post-mortem samples or in those related to accidents aids in establishing critical evidence and determining the presence or absence of Diazepam, thereby contributing to the elucidation of circumstances surrounding such cases. d. Pharmacokinetics and Research: Diazepam serves as a subject of considerable interest for researchers who seek to unravel its pharmacokinetics, metabolism, and interactions with other drugs. These investigations are fundamental in gaining a deeper understanding of Diazepam's effects and its potential applications in various therapeutic contexts. Furthermore, Diazepam research plays an instrumental role in advancing pharmacological knowledge and optimizing treatment regimens. e. Occupational Health and Safety: In specific occupational settings where vigilance, alertness, and concentration are paramount, Diazepam testing may find relevance. Ensuring employee safety and adherence to workplace safety regulations is of utmost importance. Employers may utilize Diazepam testing to ascertain the presence of Diazepam in employees' systems, particularly if its use can pose safety risks within the work environment. In summation, the precise measurement of Diazepam spans a broad spectrum of clinical, forensic, research, and safety applications. It plays an integral role in optimizing therapeutic outcomes, monitoring and managing substance abuse, providing critical evidence in forensic investigations, advancing scientific knowledge through research endeavors, and bolstering safety standards in occupational settings. Our specialized anti-Diazepam antibodies and competitive antigens serve as invaluable tools that empower the accurate detection of Diazepam, ultimately contributing to improved healthcare, safety, and the progression of scientific frontiers.

About GDU